DRUGS MADE IN AMERICA ACQUISITION CORP.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $-244.8K | $1.4K |
| FY2025 | — | $-7.3M | $6.1K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $-244.8K | $1.4K |
| FY2025 | — | $-7.3M | $6.1K |